Sangamo BioSciences Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Janney Montgomery Scott Downgrades Sangamo BioSciences (SGMO) to Neutral
August 4, 2016 7:25 AM EDTJanney Montgomery Scott downgraded Sangamo BioSciences (NASDAQ: SGMO) from Buy to Neutral with a price target of $8.00 (from $15.00).
For an analyst ratings summary and ratings history on Sangamo BioSciences click here. For more ratings news on Sangamo BioSciences click here.
Shares of Sangamo BioSciences closed at $6.84 yesterday.
... MoreSangamo Biosciences (SGMO) Misses Q2 EPS by 14c
August 3, 2016 4:36 PM EDTSangamo Biosciences (NASDAQ: SGMO) reported Q2 EPS of ($0.38), $0.14 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $5.38 million.
Financial Guidance for 2016 The Company updates guidance as follows:
Cash and Investments: Sangamo... More